A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
STAAR SURGICAL CO
STAA
$1.2B
Mkt Cap
$23.38
-3.35%
STAAR SURGICAL CO (STAA) has a 5-year average return on invested capital (ROIC) of 12.8%. This indicates solid capital allocation.
STAAR SURGICAL CO (STAA) has a market capitalization of $1.2B. It is classified as a small-cap stock.
STAAR SURGICAL CO (STAA) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.56%.
STAAR SURGICAL CO (STAA) operates in the Ophthalmic Goods industry, within the Healthcare sector.
STAAR SURGICAL CO (STAA) reported annual revenue of $239 million in its most recent fiscal year, based on SEC EDGAR filings.
STAAR SURGICAL CO (STAA) has a net profit margin of -33.6%. The company is currently unprofitable.
STAAR SURGICAL CO (STAA) generated $-40 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. We are the leading manufacturer of phakic implantable lenses used worldwide in corrective or “refractive” surgery. We have been dedicated solely to ophthalmic surgery for over 40 years. Our goal is to position our refractive lenses throughout the world as primary and premium solutions for patients seeking visual freedom from wearing eyeglasses or contact lenses while achieving excellent visual acuity through refractive vision correction. Unless the context indicates otherwise, “we,” “us,” the “Company,” and “STAAR” refer to STAAR Surgical Company and its consolidated subsidiaries. STAAR generates worldwide revenue almost exclusively from sales of our Implantable Collamer Lenses, or “ICLs.
| Metric | TTM | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 239M | 239M | 314M | 322M | 239M | 230M |
| Net Income | -80M | -80M | -20M | 21M | 40M | 28M |
| EPS | $-1.62 | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 |
| Free Cash Flow | -40M | -40M | -7.7M | -3.6M | 18M | 30M |
| ROIC | -37.9% | -23.4% | -5.2% | 7.9% | 40.7% | 43.7% |
| Gross Margin | 76.2% | 76.2% | 76.3% | 78.4% | 93.3% | 77.5% |
| Debt/Equity | 0.00 | 0.31 | 0.10 | 0.09 | 0.00 | 0.12 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -92M | -92M | -13M | 28M | 44M | 33M |
| Operating Margin | -38.3% | -38.3% | -4.0% | 8.7% | 18.3% | 14.5% |
| ROE | -23.4% | -23.4% | -5.2% | 5.9% | 13.3% | 13.1% |
| Shares Outstanding | 50M | 50M | 49M | 50M | 50M | 49M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 64M | 72M | 75M | 82M | 91M | 124M | 150M | 230M | 239M | 322M | 314M | 239M | 239M |
| Gross Margin | 69.4% | 69.7% | 65.1% | 70.8% | 70.9% | 73.8% | 74.5% | 77.5% | 93.3% | 78.4% | 76.3% | 76.2% | 76.2% |
| R&D | 6.4M | 6.7M | 12M | 21M | 20M | 22M | 25M | 34M | 36M | 40M | 45M | 40M | 40M |
| SG&A | 15M | 17M | 18M | 71M | 68M | 85M | 100M | 145M | 180M | 225M | 252M | 274M | 274M |
| EBIT | -1.2M | 700K | -8.0M | -13M | -3.6M | 6.6M | 12M | 33M | 44M | 28M | -13M | -92M | -92M |
| Op. Margin | -1.9% | 1.0% | -10.7% | -15.4% | -4.0% | 5.3% | 7.9% | 14.5% | 18.3% | 8.7% | -4.0% | -38.3% | -38.3% |
| Net Income | -1.8M | 398K | -8.4M | -12M | -2.1M | 5.0M | 14M | 28M | 40M | 21M | -20M | -80M | -80M |
| Net Margin | -2.8% | 0.6% | -11.2% | -14.7% | -2.4% | 4.0% | 9.4% | 11.9% | 16.6% | 6.6% | -6.4% | -33.6% | -33.6% |
| Non-Recurring | 2.5M | 2.0M | 321K | 1.4M | -24K | 1.5M | 1.6M | 1.7M | 2.4M | 4.8M | 1.1M | 57M | 57M |
| Returns on Capital | |||||||||||||
| ROIC | -5.8% | 2.0% | -22.1% | -31.2% | -5.1% | 17.8% | 29.0% | 43.7% | 40.7% | 7.9% | -5.2% | -23.4% | -37.9% |
| ROE | -5.8% | 1.0% | -22.1% | -32.3% | -5.3% | 5.7% | 8.8% | 13.1% | 13.3% | 5.9% | -5.2% | -23.4% | -23.4% |
| ROA | -3.4% | 0.6% | -13.9% | -19.5% | -3.2% | 4.2% | 6.8% | 9.9% | 10.4% | 4.7% | -4.0% | -17.8% | -17.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 3.2M | 3.4M | -8.0M | 1.0M | 2.9M | 13M | 26M | 44M | 36M | 15M | 16M | -34M | -34M |
| Free Cash Flow | 946K | -93K | -12M | -2.2M | 1.8M | 11M | 16M | 30M | 18M | -3.6M | -7.7M | -40M | -40M |
| Owner Earnings | -2.0M | -3.3M | -15M | -10M | -3.7M | 3.5M | 12M | 26M | 11M | -14M | -18M | -73M | -73M |
| CapEx | 2.3M | 3.4M | 4.1M | 3.2M | 1.0M | 2.2M | 10M | 14M | 18M | 18M | 23M | 5.8M | 5.8M |
| Maint. CapEx | 2.0M | 2.2M | 2.5M | 2.9M | 3.4M | 2.5M | 3.7M | 3.6M | 4.5M | 5.1M | 6.9M | 8.3M | 8.3M |
| Growth CapEx | 310K | 1.3M | 1.6M | 313K | 0 | 0 | 6.4M | 10M | 14M | 13M | 17M | 0 | 0 |
| D&A | 2.0M | 2.2M | 2.5M | 2.9M | 3.4M | 2.5M | 3.7M | 3.6M | 4.5M | 5.1M | 6.9M | 8.3M | 8.3M |
| CapEx/OCF | 70.6% | 102.8% | N/A | N/A | 36.7% | 17.6% | 39.1% | 40.1% | 50.7% | 124.6% | 148.8% | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 611K | 234K | 54K | 0 | 0 | 0 | 0 | 0 | 6.5M | 6.5M |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.6% |
| Stock-Based Comp | 3.2M | 4.5M | 4.7M | 8.6M | 3.2M | 6.8M | 11M | 15M | 20M | 24M | 27M | 31M | 31M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | -16M | -18M | -8.8M | -10M | -18M | -102M | -119M | -168M | -211M | -185M | -192M | N/A | -153M |
| Cash & Equiv. | 22M | 23M | 13M | 14M | 19M | 104M | 120M | 200M | 86M | 183M | 144M | 153M | 153M |
| Long-Term Debt | 0 | N/A | N/A | 2.8M | N/A | 459K | 366K | 382K | 210K | 42K | N/A | N/A | N/A |
| Debt/Equity | 0.18 | 0.12 | 0.11 | 0.10 | 0.02 | 0.01 | 0.01 | 0.12 | 0.00 | 0.09 | 0.10 | 0.31 | 0.00 |
| Interest Coverage | -4.2 | 4.1 | -52.1 | -113.0 | -32.4 | 50.7 | 164.6 | 5556.5 | 2576.6 | 2341.4 | -2101.8 | N/A | N/A |
| Equity | 32M | 39M | 37M | 38M | 43M | 132M | 160M | 262M | 336M | 386M | 397M | 344M | 344M |
| Total Assets | 55M | 62M | 59M | 65M | 68M | 167M | 208M | 346M | 419M | 489M | 510M | 452M | 452M |
| Total Liabilities | 23M | 23M | 22M | 28M | 25M | 35M | 48M | 87M | 83M | 103M | 112M | 107M | 107M |
| Intangibles | 2.1M | 1.4M | 870K | 473K | 271K | 243K | 296K | 218K | 173K | N/A | N/A | N/A | N/A |
| Retained Earnings | -132M | -132M | -140M | -159M | -161M | -156M | -142M | -111M | -69M | -47M | -68M | -148M | -148M |
| Working Capital | 26M | 32M | 29M | 28M | 35M | 124M | 140M | 223M | 260M | 300M | 298M | 243M | 243M |
| Current Assets | 44M | 50M | 45M | 50M | 54M | 152M | 175M | 271M | 312M | 365M | 368M | 312M | 312M |
| Current Liabilities | 18M | 18M | 16M | 21M | 19M | 28M | 34M | 49M | 52M | 65M | 70M | 69M | 69M |
| Per Share Data | |||||||||||||
| EPS | -0.05 | 0.01 | -0.22 | -297.78 | -0.05 | 0.11 | 0.30 | 0.56 | 0.80 | 0.43 | -0.41 | -1.62 | -1.62 |
| Owner EPS | -0.06 | -0.08 | -0.40 | -255.35 | -0.09 | 0.08 | 0.25 | 0.52 | 0.22 | -0.28 | -0.37 | -1.47 | -1.47 |
| Book Value | 0.90 | 0.98 | 0.97 | 930.60 | 1.00 | 2.93 | 3.41 | 5.32 | 6.78 | 7.77 | 8.06 | 6.93 | 6.93 |
| Cash Flow/Share | 0.09 | 0.08 | -0.21 | 25.75 | 0.07 | 0.28 | 0.55 | 0.89 | 0.72 | 0.29 | 0.32 | -0.69 | -1.45 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 35.3M | 39.8M | 38.1M | 0.0M | 42.8M | 45.2M | 46.8M | 49.1M | 49.6M | 49.6M | 49.3M | 49.7M | 49.7M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | 918.0 | N/A | N/A | N/A | 284.2 | 268.5 | 759.7 | 58.5 | 74.7 | N/A | N/A | -14.4 |
| P/FCF | 216.9 | N/A | N/A | N/A | 376.4 | 134.2 | 240.3 | 147.7 | 131.8 | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | 183.4 | 298.3 | 604.7 | 48.2 | 48.9 | N/A | N/A | N/A |
| Price/Book | 6.5 | N/A | 7.4 | 11.5 | 15.8 | 10.7 | 23.6 | 17.4 | 6.9 | 4.1 | 3.0 | N/A | 3.4 |
| Price/Sales | 4.6 | 7.5 | 4.2 | 3.9 | 5.4 | 10.8 | 15.6 | 36.1 | 12.6 | 8.0 | 5.6 | N/A | 4.8 |
| FCF Yield | 0.5% | -0.0% | -4.4% | -0.5% | 0.3% | 0.7% | 0.4% | 0.7% | 0.8% | -0.2% | -0.6% | N/A | -3.4% |
| Market Cap | 205M | 365M | 273M | 436M | 680M | 1.4B | 3.8B | 4.5B | 2.3B | 1.6B | 1.2B | 0 | 1.2B |
| Avg. Price | 8.33 | 13.56 | 8.26 | 7.83 | 11.43 | 29.70 | 50.11 | 119.63 | 72.38 | 52.17 | 35.62 | 0.00 | 23.38 |
| Year-End Price | 5.82 | 9.18 | 7.15 | 11.35 | 15.90 | 31.26 | 80.56 | 91.16 | 46.82 | 32.10 | 24.21 | 0.00 | 23.38 |
STAAR SURGICAL CO passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 12.8% with a gross margin of 80.3%. Total shareholder yield (buybacks) is 0.6%. At current prices, the estimated annualized return to fair value is +14.6%.
STAAR SURGICAL CO (STAA) has a debt-to-equity ratio of 0.31. This indicates a conservatively financed balance sheet.
STAAR SURGICAL CO (STAA) reported earnings per share (EPS) of $-1.62 in its most recent fiscal year.
STAAR SURGICAL CO (STAA) has a return on equity (ROE) of -23.4%. A negative ROE may indicate losses or negative equity.
STAAR SURGICAL CO (STAA) has a 5-year average gross margin of 80.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 14 years of financial data for STAAR SURGICAL CO (STAA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
STAAR SURGICAL CO (STAA) has a book value per share of $6.93, based on its most recent annual SEC filing.
No recent press releases.